Ribociclib and Spartalizumab in R/M HNSCC

Clinical trial NCT04213404 · UNKNOWN

Trial details

NCT number: NCT04213404
Sponsor: National Taiwan University Hospital
Status: UNKNOWN
Phase: Phase 1
Study type: INTERVENTIONAL

Head and Neck Squamous Cell Carcinoma

Start date: 2020-03-13
Primary completion: 2024-01-01
Enrollment: 13

View on ClinicalTrials.gov

Track trials programmatically

Sponsors, conditions and status changes through the Atlas API.